首页 | 本学科首页   官方微博 | 高级检索  
检索        

重组人粒细胞集落刺激因子在治疗急性髓细胞白血病中的应用
引用本文:施菊妹.重组人粒细胞集落刺激因子在治疗急性髓细胞白血病中的应用[J].南通医学院学报,1999,19(4):395-396.
作者姓名:施菊妹
作者单位:南通医学院附属医院血液内科!南通226001
摘    要:目的:报告重组人粒细胞集落刺激因子(rhG-CSF)在急性细胞白血病(AML)治疗中的应用及其疗效观察:方法应用中等剂量、短疗程(3-5天)rhG-CSF治疗AML28例,并与同期未用rhG-CSF治疗的AML28例进行比较。结果:rhG-CSF能显著缩短化疗后中性粒细胞计数(ANC)的低下期及感染的持续时间,同时能明显减少化疗后的输血用量。

关 键 词:白血病  AML  rhG-CSF  治疗

THE CLINICAL APPLICATION OF TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA WITH COMBINED CHEMOTHERAPY PROTOCOL PLUS RECOMBINANT HUMAN GRANULOCYTE-COLONY STIMULATING FACTOR
Shi jumei.THE CLINICAL APPLICATION OF TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA WITH COMBINED CHEMOTHERAPY PROTOCOL PLUS RECOMBINANT HUMAN GRANULOCYTE-COLONY STIMULATING FACTOR[J].ACTA Academiae Medicinae Nantong,1999,19(4):395-396.
Authors:Shi jumei
Abstract:To explore more effective modality for adult acute myelogenous leukemia,twenty-eight patients were treated with combined chemotherapy protocol plus rhG-CSF. The result suggested that the combination chemotherapy protocol plus rhG-CSF might shorten the recovery period of decreased granulocytes and enhance the control of infection with less side effectes and more safety.We conclude that the combined chemoterapy protocol plus rhG-CSF is a safer and more effective therapy for acute myelogenous leukemia patients.
Keywords:recombinant human granulocyte-colony stimulating factor  acute myelogenous leukemia
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号